Panadol Osteo and substitute drug hit by national shortage forcing user to ration pain medication

New Zealand is facing a nationwide shortage of Panadol Osteo and its alternative pain relief medication, leaving many users struggling to manage their chronic pain. The disruption in supply has prompted individuals to ration their doses, highlighting the critical reliance on these medications for daily life.

Pharmacies across the country are reporting depleted stocks, with no clear indication from manufacturers or distributors on when the supply will be replenished. The situation is particularly concerning for individuals who depend on Panadol Osteo for managing conditions like osteoarthritis, where consistent pain relief is essential.

The scarcity has led to anxiety and distress among patients, who are now faced with the difficult decision of how to best manage their pain with limited access to their usual medication. The lack of readily available alternatives further exacerbates the problem, leaving many feeling vulnerable and without adequate support for their health needs.